5.0
11 Apr 2018
Current employee, less than 1 year
Recommend
CEO approval
Business outlook
Pros
Great people, extensive knowledge and skills in the more challenging pharma areas, like sterile injectable. Ability to work on many different drugs/products. New CEO is bringing needed operational and process excellence, which will position AMRI for big growth potential in the future.
Cons
A lot of acquisitions that are not yet integrated. As mentioned in pro's- leadership recognizes the need for integration and process and operational work, which is getting underway, but will take some time.